| Term 
 | Definition 
 
        | dobutrex   : vasopressor used for decreased cardiac out put and heart failure   beta-1 agonist   do not give with beta blockers or atomoxetine   ADRS: premature ventrciular contractions, angina, dyspnea, nervousness, and HTN |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenaline   : catecholamine used as a cardiac stimulant and as a bronchodilator in cases of anaphylactic shock   potent non-selective adrenergic at both alpha and beta receptors- increases blood pressure   Do not give with MAOI's, alpha and beta blockers, or atomoxetine   ADRS- nervousness, excitability, n/v, diaphoresis, cardiac arrythmias |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Levophed   : vasocpressor used for the treatment of acute HoTN and septic shock- increases blood pressure   do not give with MAOI's, alpha and beta agonists, or atomoxetine   side effecrts: same as adrenaline |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Neo-synephrine   : vasopressor used in the treatment of paroxsymal supraventricular tachycardia   -reduces heart rate   Do not give with MAOI's, bromocriptine, alpha and beta blockers   ADRS- HTN, angina, reflex sinus bradycardia, increased risk for heart failure |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Activase   : thrombolytic agent used in MI and acute ischemic stroke   -plasminogen activator   Do not give with NSAIDS, anticoagulants, cephalosporins, and Nitroglycerin   ADRS- bleeding, arrhythmias, and angioedema |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cordarone   : class III antiarrhythmic   - delays repolarization and increases the action potential duration   IV  no longer than 3 weeks   inhibits CYP 1A2, 2C9, 2D6, and p-GP   ADRS: pulomonary, GI, rare fatal hepatotoxicity, hematological effects |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bumex   : diuretic used for edema associated with CHF, cirrhosis, and renal DX -loop diuretic   Do not give with glucocorticoids (hypokalemia), lithium, and salicylates   ADRS: muscle cramps, HoTN, hypokalemia, hyponatremia, rare renal failure |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lovenox   LMWH- DVT and STEMI   Do not giev with anticoagulants, cephalosporins, NSAIDS or protamine ( protomaine reverses effects)   ADRS: bleeding, anemia, fever, peripheral edema |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heparin   anticoagulant   do not give with anticoagulants, cephalosporins, NSAIDS or protamine   ADRS- bleeding, thrombocytopenia, hyperkalemia, and osteoporosis in long term |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Brevibloc   Class II antiarrthymic: HTN and supraventricular arrhythmias   blocks sympathetic stimulation by beta 1 receptors in the heart   Do not give with- digoxin, diltiazem, or verapamil   ADRS: HoTN, sinus bradycardia, AV block |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Primacor   : ainotropic/vasodilator agent for CHF   improves diastolic function and myocardial contractility   no significant interactions reported   ADRS: HoTN, ventricular arrhythmias, torsades |  | 
        |  | 
        
        | Term 
 
        | Cardiac   Vitamin K phytonadione |  | Definition 
 
        | Aquamephyton   : synthetic vitamin K- hypoprothrombenemia due to vitamin K deficiency   promotes liver clotting factors   do not give with warfarin or other anticoagulant TX   ADRS: Hsx rxns and injection site rxn |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Unasyn   amp- beta lactam sul- beta lactamase inhibitor max- 4gram   do not give with A/G, methotrexate, BC   ADRS- N/V/D, ab pain, hsx rxn |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pfizerpen   beta-lactam   do not give with A/G, metotrexate or BC   ADRs: N/V/D, ab pain and hsx rxn |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Zosyn   beta lactam with beta lactamase inhibitor   Crcl- 20 above- 3.375 gram over 30 min q12hr below- 3.375 g over 4 hours Q8 hrs   do not give with A/G, methotrexate, or BC   ADRs: N/V/D, ab pain and hsx rxn |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Timentin   beta lactam with competitive inhibitor of beta lactamase   do not give with A/g, methotrexate, or bc   ADR's- N/V/D, ab paina nd hsx rxn |  | 
        |  | 
        
        | Term 
 
        | ceph/penn     Cefazolin sodium |  | Definition 
 
        | Ancef   cephalosporins- cell lysis   MDD- 12 grams   do not give with chloramphenicol- inhibits   ADRs- H/A, hsx rxns, neutropenia, interstitial nephritis   1st gen: gram + (lil gram -) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | maxipime   cell lysis- cephalosporin   do not give with chloramphenicol   ADRS: H/A, hsx rxn, netropenia, and interstital nephritis   4 generation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | clarforan   cell lysis   do not give with chloramphenicol   H/A, hsx rxn, netropenia, and interstitial nephritis   3rd generation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fortaz; Tazidime   cell lysis   do not give with chloramphenicol   h/A, hsx rxn, neutropenia, and interstital nephritis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rocephin   cell lysis   1-2 g Q 24 hours 2 grams Q 12 hours for meningitis   do not give with chloramphenicol   H/A, hsx rxn, neutropenia, interstitial nephritis   3rd generation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Zinacef   cell lysis   do not give with chloramphenicol   H/A, hsx rxn, neutropenia, and interstitial nephritis   2 generation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Garamycin   A/G   bind to 30 s and make non-functional proteins   Traditional : 3-6 mg/kg/day in 2-3 divided doses HDODA: 5-7 mg/kg/day   levels drwan 8-12 hours after first dose Dose for renal impairment   Do not give with acyclovir, AMP B, cidofovir, cisplatin, or loop diuretics   nephro and oto- toxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A/G Nebcin   Tradtional and HDODA   dose for renal adjustment   do not give with acyclovir, amp B, cidofovir, cisplatin, or loop diuretics   nephro and oto - toxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Vancocin   MRSA   glycopeptide abx alterates celll wall and RNA synthesis   infuse over atleast 1 hour doses adjusted based on vanco trough level dosed for renal impairment   Do not give with A/G, cidofovir, anesthetics (anaphylaxsis), and metformin (lactic acidosis)   Oto and nephro toxicity, red man syndrome and neutropenia   oral formulation is not systemically absorbed |  | 
        |  | 
        
        | Term 
 
        | Erythromycin lactobionate |  | Definition 
 
        | Erythrocin   macrolide- bacterostatic binds to 50 s   MDD- 4 grams dose reduction for renal failure   inhibitor of 3A4 and p-GP   ADRS: acute generalized exanthematous pustulosis, diarrhea, ab pain and jaundice   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Primaxin   imipenem- abx cilastain- inhibitor of DHP=1 binds to penn. binding proteins   Higher dose in CF patients and dose reduction in renal impairment   Do not give with probenacid( prolonged levels), valproic acid (decreased levels) or theophylline (seizures)   ADRS- n/v/d, psuedomembranous colitis, seizures |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Zyvox   ventilator associated pneumonia- MRSA   MRSA   vancomycin resistance enterococcus faecium   oxazolidinone abx- interferes with transolation and is a reversible non-selective MAOI   Do not give with MAOI (HTN crisis), beta agonists, tyramine foods, or caffeine   ADRS- N/V/D, lactic acidosis, HTN, thrombocytopenia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fungizone   polyene antifungal- binds to sterols   MDD 1.5 g   dosing differs for formulation   do not give with A/G, cidofovir, loop or thiazide diuretics- hypokalemia   ADRs- nephrotoxicity, electrolyte loss, anaphylaxsis, anemia   liposomal formulation- false high serum phosphate concentrations |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cancidas   echinocandin antifungal   70 mg loading dose 50 mg QD over 1 hour   Do not give with cyclosporin (increases), carbamazepine, dexamethason, or phenytoin (decreases)   ADRS: fever, infusion rxns, elevated hepatic enzymes, pulmonary edema |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Duragesic; Actiq; sublimaze   persistant to moderate pain requiring continuous opioid analgesics   mu receptor agonist   Do not give with 3A4 metabolized drugs- azole antifungals, phenytoin, erythormycin, or amiodarone (HoTN), or NO (resp. depression)   ADRS- risk of abuse, chest pain, arrythmias, syncope, chest wall rigidity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dilaudid   mod- severe pain   mu agonist   do not give with barbituates- increases CNS depression or MAOI's- coma and death   ADRs- constiptaion, bradycardia, resp. depression, palpitation, dizzy and drowsy   4-7 times more potent that morphine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Demerol   active metabolite- normeperidine- may accumulate and precipitate twitches and tremors or seizures- not first line choice for pain management   mu agonist   Do not give with subutramine (serotonin sydrome) or phenytoin ( decreased effects)   ADRS: constipation, flushing, bradycardia, resp. depression, palpitation, phlebitis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   mu agonist   dose dependent on condition   do not give with other CNS depressants   ADRS: constipation, bradycarida, resp. dep, flushing, vasodilation, confusion, dizzy, drowsy, hallucinations, H/A, and withdrawal |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Narcan   - indicated for the complete or partial reversal of opioid overdose   narcotic antagonist- competes for the mu receptor but produces no effect   short half life- repetition may be needed   C/I- none to date   ADRS: nausea, vomiting, sweating, tachycardia, increased BP- all from reversal of opioid effects     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Versed   prespective sedation or anti-anxiety or general anesthesia   short acting Benzo reversible inhibition of GABA receptor   Do not give with CNS depressants or 3A4 drugs- cimetidine, erythromycin, diltiazem, ketoconazole   ADRs: H/A, admin irritation, nausea, vomiting, over sedation, and drowsy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Toradil   short term pain- under 5 days   NSAID   ADRs- peptic ulcers, GI bleed, hsx, HTN, palpitations, syncope |  | 
        |  | 
        
        | Term 
 
        | Dexamethasone sodium phosphate |  | Definition 
 
        | Decadron   : RA, adrenal gland disorders, resp. dx, autoimmune Dx, GI DX, dermatologic conditions and allergic conditions   anti-inflammatory- also breaks down skeletal muscle, fat, bone, and suppresses immune system- inhibits leukocyte migration to site of inflammation   Do not give with barbituates- decreases B.C and ketoconazole, macrolides- increases Digoxin- digoxin toxicity   ADRS: HPA axis supression, insomnia, delayed hsx, osteoporosis, cataracts, glaucoma, glucose intolerence, weight gain, hypokalemia, altered mood, peptic ulcers, GI bleed, infection suseptibility |  | 
        |  | 
        
        | Term 
 
        | Hydrocortisone sodium succinate |  | Definition 
 
        | Solu-cortef   many DX states dealing with inflammation   same as decadron- indication, MOA, what to stay away from, and ADRS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | xylocaine   local or regional anethesia and acute management of cardiac arrythmias   prevent generation and conduction or nerve impulses   do not give with sedatives   Adrs- myocardial depression, HoTN, N/V/D, tinnitus, blurred vision |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Diprivan   anasthesia- induces and maintains sedation- monitored and ICU   IV hypnotic/sedative that works rapidly mechanical ventilation is needed for continuous IV   Do not give with CNS depressants   Adrs- resp dep, HoTN, movement effects, vomiting, apnea |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inapsine   :reduce the incidence of N and V   antagonist of apomorphine- a dopaminergic agonist to produce the antiemetic effect   cardio should be monitored   Do not give with agents that prolong QT intervals: antiarryhthmics, CCB's, antidepressants or parenteral analgesics- fentantyl- HTN   BBW: QT prolongation and torsades ADRS- palpitations, HoTN, tachcardia   C/I- QTc > 440 msec |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Zofran   N/V- chemo and radiation   selective serotonin antagonist- vagal nerve, GI, CTZ   do not give with riframpin- decrease or serotonin drugs- serotonin syndrome |  | 
        |  | 
        
        | Term 
 
        | Prochlorperazine edisylate |  | Definition 
 
        | Compazine   - control severe N/V schizophrenia and non-psychotic anxiety   MOA- unknown   MDD: 40 mg/day   do not give with p450 pathway, thiazide diuretics (HoTN), or merperidine (excessive sedation)   ADRs: cardiac arrest, HoTN, ECG changes, dizzy, drowsy, dyskinesia, extrapyrimidal sx, insomnia, dry mouth, and constiptation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Procrit; Epogen   Anemia stimulates erythropoeis by syimulating bone marrow turnover want: Hg rance 10-12 g/dl   none to date- interactions   ADRs- immunogenicity, HTN, seizure, thrombotic evetns, allergic rxns |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Humulin R, novolin R   DM 1 and 2- not controlled by diet and exercise hyperkalemia and severe ketoacidosis   Lowers blood glucose hyperkalemia- shift in K cells lowering serum potassium   Avoid drugs: increases hyerglycemic affect- ACE, BB, alcohol, fibrates and that decrease hypoglycemic affect- albuertol, phenytoin, and BC   ADRs: hypoglycemia, hypokalemia, injection site reaction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | INFeD; DexFerrum   iron deficiency when PO is N/A   D/C oral iron before start- test before give- dosage based off individual patient and chart or calculated   Avoid: chloramphenicol- increases iron BBW- anaphylaxsis, arrythmias, cyanosis, and CV effects   requires a test dose to be given before adminsitration to prevent anaphylaxsis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | used to replace magnesium deficiencies such as acute hypomanesiumia   ADr's- flushing, sweating, HoTN, hypothermia, as a result of magnesum intoxication   need to monitor levels |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pitocin   for the initiation or improvement of uterine contractions   acts on smooth muscle of the uterus to stimulate contractions   ADRs: cardiac arrythmias, N/V, hypertensive episodes, pelvic hematoma, postpartum hemorrhage |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | used for metabolic acidosis, urinary alkalinization, severe diarrhea   increases plasma bicarbonate and buffers excess hydrogen ion concentration to raise blood pH to reverse acidosis   individually monitored and dosed   ADRs- cellulitis with tissue necrosis, local pain and irritation |  | 
        |  |